Drug AVASTIN (Bevacizumab Injection) not to be used in Opthalmology.
Drug AVASTIN (Bevacizumab Injection) not to be used in Opthalmology
Drug AVASTIN (Bevacizumab Injection) not to be used in Opthalmology. Read More »
Drug AVASTIN (Bevacizumab Injection) not to be used in Opthalmology
Drug AVASTIN (Bevacizumab Injection) not to be used in Opthalmology. Read More »
Approval of the safety and efficacy of Fixed Dose Combinations (FDCs) permitted for manufacture for sale in the country without due approval from office of DCG(I)
“Box Warning” on the label as well as package insert and other promotional literature of formulations containing Nimesulide
“Implementation of the Drugs & Cosmetics (Fourth Amendment) Rules, 2013 published under Gazette notification G.S.R. 558(E) dated 30.08.2013. regarding the inclusion of Schedule H1 under the Drugs & Cosmetics Rules, 1945- Clarification thereon.”
FDA NEW BUILDING CONTACT DETAILS
FDA NEW BUILDING CONTACT DETAILS Read More »
Exemption of Veterinary products from the purview of DCG(I) letter dated 15.01.2013
Exemption of Veterinary products from the purview of DCG(I) letter dated 15.01.2013 Read More »
Important safety label changes to Carbamazepine containing products
Important safety label changes to Carbamazepine containing products Read More »
Issue of licensing of milk and milk products
Issue of licensing of milk and milk products Read More »
Bringing details about Drug import alert/ restrictions imposed by regulatory authorities abroad to the notice of CDSCO as well as State Drug Control Authorities.